Arecor Therapeutics PLC - West Sussex, England-based biopharmaceutical firm - Delays publication of 2023 results, which were due to be published Tuesday next week. Says its auditor, Grant Thornton UK LLP, requires more time to complete procedures. Says it will now announce its results in the week commencing May 13.

Current stock price: 137.84 pence

12-month change: down 49%

Copyright 2024 Alliance News Ltd. All Rights Reserved.